FI831431A0 - Bensotiazolinfoereningar - Google Patents
BensotiazolinfoereningarInfo
- Publication number
- FI831431A0 FI831431A0 FI831431A FI831431A FI831431A0 FI 831431 A0 FI831431 A0 FI 831431A0 FI 831431 A FI831431 A FI 831431A FI 831431 A FI831431 A FI 831431A FI 831431 A0 FI831431 A0 FI 831431A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- hydrogen
- alkanoyl
- alkyl
- substituted
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001589 carboacyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14414881 | 1981-09-12 | ||
| JP56144148A JPS5846079A (ja) | 1981-09-12 | 1981-09-12 | ベンゾチアゾリン環を有するエ−テル類 |
| PCT/JP1982/000363 WO1983000865A1 (en) | 1981-09-12 | 1982-09-10 | Benzothiazoline compounds |
| JP8200363 | 1982-09-10 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI831431L FI831431L (fi) | 1983-04-27 |
| FI831431A0 true FI831431A0 (fi) | 1983-04-27 |
| FI68232B FI68232B (fi) | 1985-04-30 |
| FI68232C FI68232C (fi) | 1985-08-12 |
Family
ID=15355326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI831431A FI68232C (fi) | 1981-09-12 | 1983-04-27 | Foerfarande foer framstaellning av benzotiazolinfoereningar me farmaceutiskt verkan |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US4479949A (fi) |
| JP (1) | JPS5846079A (fi) |
| AT (1) | AT379592B (fi) |
| AU (1) | AU541223B2 (fi) |
| BE (1) | BE894358A (fi) |
| CA (1) | CA1169860A (fi) |
| CH (1) | CH654001A5 (fi) |
| DE (1) | DE3248957T1 (fi) |
| DK (1) | DK164403C (fi) |
| ES (2) | ES515655A0 (fi) |
| FI (1) | FI68232C (fi) |
| FR (1) | FR2512820B1 (fi) |
| GB (1) | GB2115815B (fi) |
| IT (1) | IT1196423B (fi) |
| NL (1) | NL8220310A (fi) |
| NO (1) | NO831653L (fi) |
| SE (1) | SE444681B (fi) |
| WO (1) | WO1983000865A1 (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56164877A (en) * | 1980-05-23 | 1981-12-18 | Fujitsu Ltd | Manufacture of head for thermal printer |
| JPS5846079A (ja) * | 1981-09-12 | 1983-03-17 | Santen Pharmaceut Co Ltd | ベンゾチアゾリン環を有するエ−テル類 |
| DK143684A (da) * | 1983-03-12 | 1984-09-13 | Bayer Ag | Anvendelse af pyrazolonderivater som lipoxygenasehaemmer ved terapi af isaer ischaemi og hjerterytmeforstyrrelser |
| JPS60139679A (ja) * | 1983-12-27 | 1985-07-24 | Santen Pharmaceut Co Ltd | ２−アリ−ルベンゾチアゾリン誘導体 |
| JPS60207396A (ja) * | 1984-03-31 | 1985-10-18 | ロ−ム株式会社 | 配線基板 |
| JPS61110568A (ja) * | 1984-10-31 | 1986-05-28 | アルカテル・エヌ・ブイ | プリンタ装置 |
| US4728651A (en) * | 1985-10-24 | 1988-03-01 | Hoechst-Roussel Pharmaceuticals Inc. | Antihypertensive thieno-isoxazoles and -pyrazoles |
| JPS62221679A (ja) * | 1986-03-19 | 1987-09-29 | Santen Pharmaceut Co Ltd | ベンゾチアゾリン誘導体 |
| US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
| US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| US7112598B2 (en) | 2002-03-29 | 2006-09-26 | Santen Pharmaceutical Co., Ltd. | κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| WO2014148574A1 (ja) * | 2013-03-22 | 2014-09-25 | 参天製薬株式会社 | Ｉｌ－２産生抑制 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2996512A (en) * | 1961-08-15 | Therapeutic derivatives of aryl- | ||
| US3117124A (en) * | 1957-03-20 | 1964-01-07 | Olin Mathieson | Benzothiazole, benzothiazine, and benzothiazepine compounds |
| FR1255312A (fr) * | 1957-10-31 | 1961-03-10 | Crookes Lab Ltd | Dérivés des aryl-benzothiazoles et leur mode de préparation |
| GB1058822A (en) * | 1963-07-30 | 1967-02-15 | Ici Ltd | 3-amino-2-hydroxypropoxy heterocyclic derivatives |
| GB1047927A (en) * | 1964-03-09 | 1966-11-09 | Ici Ltd | Alkanolamine derivatives |
| BE754245A (fr) * | 1969-08-01 | 1970-12-31 | Sumitomo Chemical Co | Derives d'acides phenoxy carboxyliques |
| US3574218A (en) * | 1969-08-11 | 1971-04-06 | Egyt Gyogyszervegyeszeti Gyar | 2-aryl- or aralkyl-substituted benzazole derivatives |
| US3720683A (en) * | 1970-09-02 | 1973-03-13 | Squibb & Sons Inc | 2-phenyl-3-acylbenzothiazolines and their oxides |
| JPS5371071A (en) * | 1976-12-08 | 1978-06-24 | Teijin Ltd | Alpha-phenoxyacetic acid derivs. |
| JPS57179175A (en) * | 1981-04-30 | 1982-11-04 | Shinzo Kano | Preparation of 2-benzothiazolinone derivative or salt thereof |
| JPS5846079A (ja) * | 1981-09-12 | 1983-03-17 | Santen Pharmaceut Co Ltd | ベンゾチアゾリン環を有するエ−テル類 |
-
1981
- 1981-09-12 JP JP56144148A patent/JPS5846079A/ja active Pending
-
1982
- 1982-09-07 IT IT23146/82A patent/IT1196423B/it active
- 1982-09-10 GB GB08311096A patent/GB2115815B/en not_active Expired
- 1982-09-10 NL NL8220310A patent/NL8220310A/nl not_active Application Discontinuation
- 1982-09-10 WO PCT/JP1982/000363 patent/WO1983000865A1/ja active IP Right Grant
- 1982-09-10 ES ES515655A patent/ES515655A0/es active Granted
- 1982-09-10 DE DE823248957T patent/DE3248957T1/de active Granted
- 1982-09-10 US US06/503,160 patent/US4479949A/en not_active Expired - Lifetime
- 1982-09-10 CH CH2716/83A patent/CH654001A5/de not_active IP Right Cessation
- 1982-09-10 AT AT0904882A patent/AT379592B/de not_active IP Right Cessation
- 1982-09-10 CA CA000411159A patent/CA1169860A/en not_active Expired
- 1982-09-10 AU AU89026/82A patent/AU541223B2/en not_active Ceased
- 1982-09-10 BE BE2/59831A patent/BE894358A/fr not_active IP Right Cessation
- 1982-09-13 FR FR8215454A patent/FR2512820B1/fr not_active Expired
-
1983
- 1983-04-26 SE SE8302352A patent/SE444681B/sv not_active IP Right Cessation
- 1983-04-27 FI FI831431A patent/FI68232C/fi not_active IP Right Cessation
- 1983-05-10 NO NO831653A patent/NO831653L/no unknown
- 1983-05-11 DK DK211283A patent/DK164403C/da not_active IP Right Cessation
- 1983-05-13 ES ES522386A patent/ES8407033A1/es not_active Expired
-
1984
- 1984-05-21 US US06/612,323 patent/US4558125A/en not_active Expired - Fee Related
- 1984-05-21 US US06/612,322 patent/US4552969A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES486349A1 (es) | Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas | |
| MA20459A1 (fr) | Derives de l'imidazol-1,5-a/-pyridine substitues | |
| NO159795C (no) | Fremgangsmaate for fremstilling av 2-penemforbindelser. | |
| AR002690A1 (es) | Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado. | |
| NZ220835A (en) | 5-alkoxy-2,4-diamino-alkylbenzenes and their use in hair dyeing agents | |
| IT1196423B (it) | Benzotiazolin-composti | |
| JPS5598179A (en) | Novel arylether*its manufacture and drug containing same for treating allergic disease | |
| ZA889023B (en) | 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them | |
| ES8800571A1 (es) | Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona. | |
| ES8202818A1 (es) | Un procedimiento para preparar derivados de tetrazolilcuma- rina | |
| ES2139247T3 (es) | Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles. | |
| ATE100439T1 (de) | 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate. | |
| ES8600224A1 (es) | Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles | |
| IL61560A0 (en) | 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
| FI872997A (fi) | Amidderivat. | |
| DK601783A (da) | Resorcinderivater | |
| DE3166665D1 (en) | Dibenzocycloheptenylidenes and their use in pharmaceutical compositions | |
| ES528458A0 (es) | Procedimiento de preparacion de nuevos derivados 4-hidroxi- -etil-benzoles | |
| IT1175915B (it) | Preparati farmaceutici ad azione analgesica contenenti 5 fenil-1, 4-benzodiazepine | |
| ATE19629T1 (de) | N-substituierte derivate des tetrahydroisophthalimids. | |
| GB2011399A (en) | Bactericidal compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: SANTEN PHARMACEUTICAL CO., LTD |